Genetic Etiology for Alcohol-Induced Cardiac Toxicity
James S Ware, Almudena Amor-Salamanca, Upasana Tayal, Risha Govind, Isabel Serrano, Joel Salazar-Mendiguchía, Jose Manuel García-Pinilla, Domingo A Pascual-Figal, Julio Nuñez, Gonzalo Guzzo-Merello, Emiliano Gonzalez-Vioque, Alfredo Bardaji, Nicolas Manito, Miguel A López-Garrido, Laura Padron-Barthe, Elizabeth Edwards, Nicola Whiffin, Roddy Walsh, Rachel J Buchan, William Midwinter, Alicja Wilk, Sanjay Prasad, Antonis Pantazis, John Baski, Declan P O'Regan, Luis Alonso-Pulpon, Stuart A Cook, Enrique Lara-Pezzi, Paul J Barton, Pablo Garcia-Pavia, James S Ware, Almudena Amor-Salamanca, Upasana Tayal, Risha Govind, Isabel Serrano, Joel Salazar-Mendiguchía, Jose Manuel García-Pinilla, Domingo A Pascual-Figal, Julio Nuñez, Gonzalo Guzzo-Merello, Emiliano Gonzalez-Vioque, Alfredo Bardaji, Nicolas Manito, Miguel A López-Garrido, Laura Padron-Barthe, Elizabeth Edwards, Nicola Whiffin, Roddy Walsh, Rachel J Buchan, William Midwinter, Alicja Wilk, Sanjay Prasad, Antonis Pantazis, John Baski, Declan P O'Regan, Luis Alonso-Pulpon, Stuart A Cook, Enrique Lara-Pezzi, Paul J Barton, Pablo Garcia-Pavia
Abstract
Background: Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic excess alcohol consumption. It is largely unknown which factors determine cardiac toxicity on exposure to alcohol.
Objectives: This study sought to evaluate the role of variation in cardiomyopathy-associated genes in the pathophysiology of ACM, and to examine the effects of alcohol intake and genotype on dilated cardiomyopathy (DCM) severity.
Methods: The authors characterized 141 ACM cases, 716 DCM cases, and 445 healthy volunteers. The authors compared the prevalence of rare, protein-altering variants in 9 genes associated with inherited DCM. They evaluated the effect of genotype and alcohol consumption on phenotype in DCM.
Results: Variants in well-characterized DCM-causing genes were more prevalent in patients with ACM than control subjects (13.5% vs. 2.9%; p = 1.2 ×10-5), but similar between patients with ACM and DCM (19.4%; p = 0.12) and with a predominant burden of titin truncating variants (TTNtv) (9.9%). Separately, we identified an interaction between TTN genotype and excess alcohol consumption in a cohort of DCM patients not meeting ACM criteria. On multivariate analysis, DCM patients with a TTNtv who consumed excess alcohol had an 8.7% absolute reduction in ejection fraction (95% confidence interval: -2.3% to -15.1%; p < 0.007) compared with those without TTNtv and excess alcohol consumption. The presence of TTNtv did not predict phenotype, outcome, or functional recovery on treatment in ACM patients.
Conclusions: TTNtv represent a prevalent genetic predisposition for ACM, and are also associated with a worse left ventricular ejection fraction in DCM patients who consume alcohol above recommended levels. Familial evaluation and genetic testing should be considered in patients presenting with ACM.
Keywords: alcohol; dilated cardiomyopathy; genetics; titin; variant.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
- Urbano-Marquez A., Estruch R., Navarro-Lopez F., Grau J.M., Mont L., Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409–415.
- Fernandez-Sola J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015;12:576–587.
- Guzzo-Merello G., Segovia J., Dominguez F. Natural history and prognostic factors in alcoholic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:78–86.
- George A., Figueredo V.M. Alcoholic cardiomyopathy: a review. J Card Fail. 2011;17:844–849.
- Xi B., Veeranki S.P., Zhao M., Ma C., Yan Y., Mi J. Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. adults. J Am Coll Cardiol. 2017;70:913–922.
- Guzzo-Merello G., Cobo-Marcos M., Gallego-Delgado M., Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014;6:771–781.
- Fernandez-Sola J., Nicolas J.M., Oriola J. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med. 2002;137:321–326.
- Teragaki M., Takeuchi K., Toda I. Point mutations in mitochondrial DNA of patients with alcoholic cardiomyopathy. Heart Vessels. 2000;15:172–175.
- Guzzo-Merello G., Dominguez F., Gonzalez-Lopez E. Malignant ventricular arrhythmias in alcoholic cardiomyopathy. Int J Cardiol. 2015;199:99–105.
- Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531–547.
- Herman D.S., Lam L., Taylor M.R. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619–628.
- Roberts A.M., Ware J.S., Herman D.S. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015;7:270ra6.
- Tayal U., Prasad S., Cook S.A. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Med. 2017;9:20.
- Ware J.S., Li J., Mazaika E. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374:233–241.
- Schafer S., de Marvao A., Adami E. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet. 2017;49:46–53.
- Amor-Salamanca A., Guzzo-Merello G., González-López E. Prognostic impact and predictors of ejection fraction recovery in patients with alcoholic cardiomyopathy. Rev Esp Cardiol. 2018 Feb 8 [E-pub ahead of print]
- Tayal U., Newsome S., Buchan R. Integrated analysis of the phenotype and clinical outcomes of Titin cardiomyopathy. J Am Coll Cardiol. 2017;70:2264–2274.
- Maceira A.M., Prasad S.K., Khan M., Pennell D.J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417–426.
- Pua C.J., Bhalshankar J., Miao K. Development of a comprehensive sequencing assay for inherited cardiac condition genes. J Cardiovasc Transl Res. 2016;9:3–11.
- Whiffin N., Minikel E., Walsh R. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med. 2017;19:1151–1158.
- Walsh R., Thomson K.L., Ware J.S. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19:192–203.
- Committee HoCSaT. Alcohol guidelines: Eleventh Report of Session 2010-12: UK Parliament, 2012.
- Royal Colleges of Physicians, Psychiatrists and General Practitioners . Royal Colleges of Physicians; London: 1995. Alcohol and the Heart in Perspective: Sensible Limits Reaffirmed.
- ImperialCardioGenetics/ACM. Available at: . Accessed April 15, 2018.
- Chami N., Tadros R., Lemarbre F. Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians. Can J Cardiol. 2014;30:1655–1661.
- Richards S., Aziz N., Bale S. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
- Ware J.S., Cook S.A. Role of titin in cardiomyopathy: from DNA variants to patient stratification. Nat Rev Cardiol. 2018;15:241–252.
- Bell S., Daskalopoulou M., Rapsomaniki E. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017;356:j909.
- Belkaya S., Kontorovich A.R., Byun M. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J Am Coll Cardiol. 2017;69:1653–1665.
- Marinescu V., McCullough P.A. Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and therapeutic implications. Expert Rev Cardiovasc Ther. 2011;9:1161–1170.
- Frustaci A., Russo M.A., Morgante E. Oxidative myocardial damage in human cocaine-related cardiomyopathy. Eur J Heart Fail. 2015;17:283–290.
- Chang H.M., Okwuosa T.M., Scarabelli T. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol. 2017;70:2552–2565.
- Felkin L.E., Walsh R., Ware J.S. Recovery of cardiac function in cardiomyopathy caused by titin truncation. JAMA Cardiol. 2016;1:234–235.
- Jansweijer J.A., Nieuwhof K., Russo F. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail. 2017;19:512–521.
Source: PubMed